期刊文献+

过氧化物酶增殖物激活受体β/δ在银屑病角质形成细胞中的表达 被引量:5

Expression of peroxisome proliferator-activated receptor β/δ in psoriatic epidermal keratinocytes
原文传递
导出
摘要 目的 探讨过氧化物酶增殖物激活受体β/δ (PPARβ/δ)在银屑病患者表皮角质形成细胞(KC)中的表达和调节因素.方法 免疫组化方法检测PPARβ/δ在银屑病患者皮损及非皮损表皮中的表达.分离、培养银屑病患者非皮损区和皮损区的KC,以RT-PCR和Western印迹法分别检测银屑病患者皮损区和非皮损区KC中PPARβ/δ mRNA和蛋白质的表达水平.利用PPARβ/δ外源性激动剂GW501516及Ca2+刺激银屑病非皮损区KC,观察其对PPARβ/δ表达的调节影响.结果 免疫组化显示,银屑病皮损区PPARβ/δ的表达强度显著高于正常对照组(t=19.28,P<0.01)和非皮损区(t=23.26,P<0.01).银屑病皮损区PPARβ/δ mRNA和蛋白质的表达水平均高于正常对照组(P<0.01)和非皮损区(P< 0.01).10 ng/ml GW501516最大效能促进PPARβ/δ的表达(P< 0.01);1.0 mmol/L Ca2+对KC中PPARβ/δ的表达促进效应最明显(P<0.01).结论 PPARβ/δ在银屑病患者皮损区表达显著升高,GW501516和CaCa2+能够促进角质形成细胞PPARβ/δ表达水平. Objective To measure the expression of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in epidermal keratinocytes from patients with psoriasis,and to investigate its regulatory factors.Methods Tissue specimens were obtained from both lesional and non-lesional skin of 20 patients with psoriasis as well as from normal skin of 15 human controls.An immunohistochemical method was used to examine the expression of PPARβ/δ in these tissue specimens.Epidermal keratinocytes were isolated from these tissue specimens and subjected to a primary culture.After several passages of subculture,non-lesional psoriatic keratinocytes were stimulated with different concentrations of GW501516 (an agonist of PPARβ/δ,0-100 ng/ml) and Ca2+ (0-3.0 mmol/L).Reverse transcription-PCR and Western blot were performed to measure the mRNA and protein expressions of PPARβ/δ in the primary keratinocytes and stimulated keratinocytes respectively.Results Immunohistochemistry showed that the expression intensity of PPARβ/δ was significantly higher in lesional psoriatic skin than in normal control skin (t =19.28,P < 0.01) and non-lesional psoriatic skin (t =23.26,P < 0.01).Increased mRNA and protein levels of PPARβ/δ were observed in lesional psoriatic keratinocytes as compared to normal control keratinocytes (both P <0.01) and non-lesional psoriatic keratinocytes (both P < 0.01).Among these stimulated non-lesional psoriatic keratinocytes,those treated with GW501516 at 10 ng/ml and those with Ca2+ of 1.0 mmol/L showed the strongest expression of PPARβ/δ (both P < 0.01).Conclusions The expression of PPARβ/δ,which is higher in lesional psoriatic skin,can be enhanced by GW501516 and Ca2+ in keratinocytes.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2014年第10期719-722,共4页 Chinese Journal of Dermatology
基金 广东省自然科学基金(S2012040006694) 广东省医学科研基金(B2012329) 深圳市科技计划项目(201203035)
关键词 银屑病 角蛋白细胞 过氧化物酶体增生物激活受体β/δ Psoriasis Keratinocytes PPARβ/δ
  • 相关文献

参考文献12

  • 1Man MQ, Barish GD, Schmuth M, et al. Deficiency of PPARB/8 in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation [J]. J Invest Dermatol, 2008, 128(2): 370-377.
  • 2Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors in cutaneous biology[J]. Br J Dermatol, 2003, 149(2): 229-236.
  • 3Romauowska M, Reilly L, Palmer CN, et al. Activation of PPARbeta/ delta causes a psoriasis-like skin disease in vivo [Jl. PLoS One, 2010, 16, 5(3): e9701.
  • 4al Yacoub N, Romanowska M, Krauss S, et al. PPARdelta is a type 1 IFN target gene and inhibits apoptosis in T cells [J]. J Invest Dermatol, 2008, 128(8): 1940-1949.
  • 5Villarrubia VG, Vidal-Asensi S, Perez-Bafiaseo V, et al. Lipid nutrition and the epidermal barrier: The connection between immune-mediated inflammatory diseases and peroxisome proliferator-activated receptors, a new therapeutic target in psoriasis and atopic dermatitis [J]. Actas Dermosifiliogr, 2010, 101(7): 585-599.
  • 6庞晓文,杨雪琴,张萍,朱赛楠.过氧化物酶体增殖物激活受体在寻常性银屑病患者表皮中的表达[J].中华皮肤科杂志,2011,44(7):519-521. 被引量:3
  • 7Romanowska M, al Yacoub N, Seidel H, et al. PPARdeha enhances keratinocyte proliferation in psoriasis and induces heparin- binding EGF-like growth factor[Jl. J Invest Dermatol, 2008, 128 (1): 110-124.
  • 8El Eishi N, Hegazy R, Abou Zeid O, et al. Peroxisome proliferator receptor (PPAR) 13/δ in psoriatic patients before and after two conventional therapeutic modalitics: methotrexate and PUVA[J]. Eur J Dermatol, 2011, 21(5): 691-695.
  • 9Hao CM, Redha R, Morrow J, et al. Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress[J]. J Biol Chem, 2002, 277(24): 21341-21345.
  • 10Burdick AD, Bility MT, Girroir EE, et al. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/ delta) inhibits cell growth of human N/TERT-1 keratinoeytes[J]. Cell Signal, 2007, 19 (6): 1163-1171.

二级参考文献9

  • 1蔄茂强,孔祥明,张信江.过氧化体增生激活受体对皮肤的生物调节作用[J].临床皮肤科杂志,2007,36(3):184-186. 被引量:4
  • 2Westergaard M, Henningsen J, Johansen C, et al. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol, 2003, 121 (5) : 1104-1117.
  • 3Burdick AD, Kim DJ, Peraza MA, et al. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell Signal, 2006, 18( 1 ): 9-20.
  • 4Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors as new molecular targets in psoriasis. Curr Drug Targets Inflamm Allergy, 2004, 3(2): 205-211.
  • 5Berger J, Wagner JA. Physiological and therapeutic roles of peroxisome proliferator-activated receptors. Diabetes Technol Ther 2002, 4(2): 163-174.
  • 6Green S. PPAR: a mediator of peroxisomc proliferator action. Mutat Res, 1995, 333(1-2): 101-109.
  • 7Komtives LG, Hanley K, Man MQ, et al. Keratinocyte differentia- tion in hyperproliferative epidermis: topical application of PPAR- alpha activators restores tissue homeostasis. J Invest Dermatol,2000, 115(3): 361-367.
  • 8Schmuth M, Haqq CM, Cairns WJ, et al. Peroxisome proliferator- activated receptor (PPAR)-beta/deha stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol, 2004, 122(4): 971-983.
  • 9Man MQ, Choi EH, Schmuth M, et al. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol, 2006, 126(2): 386-392.

共引文献2

同被引文献27

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部